Kalaris Therapeutics (KLRS) Stock Chart & Stock Price History $4.08 +0.52 (+14.61%) As of 08/29/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsOwnershipSEC FilingsTrendsBuy This Stock Kalaris Therapeutics Stock Price Performance The Kalaris Therapeutics (KLRS) stock chart highlights key performance trends across multiple timeframes. In the past month, the stock has increased 51.67%, reflecting recent market activity. As of the latest close, Kalaris Therapeutics traded at $4.08 with a market cap of $76.30 million and volume of 60,982 shares. Receive KLRS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Kalaris Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+62.55%1 Month Performance+51.67%3 Month Performance+39.73% KLRS Stock Chart for Saturday, August, 30, 2025 KLRS Chart by TradingView Kalaris Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/29/2025$3.56$4.08+14.61%$4.14$3.5660,982 shs$76.30 million08/28/2025$3.08$3.56+15.58%$3.96$3.08328,105 shs$66.57 million08/27/2025$2.56$3.08+20.31%$3.26$2.55429,389 shs$57.60 million08/26/2025$2.51$2.56+1.99%$2.65$2.5331,249 shs$47.88 million08/25/2025$2.51$2.51$2.56$2.5027,544 shs$46.94 million08/22/2025$2.46$2.51+2.03%$2.58$2.3767,709 shs$46.94 million08/21/2025$2.57$2.46-4.28%$2.55$2.4410,797 shs$46.00 million08/20/2025$2.57$2.57$2.64$2.4728,661 shs$48.06 million08/19/2025$2.50$2.57+2.80%$2.64$2.4424,846 shs$48.06 million08/18/2025$2.46$2.50+1.63%$2.60$2.3655,249 shs$46.75 million Get the Latest News and Ratings for KLRS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kalaris Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 08/15/2025$2.27$2.46+8.37%$2.48$2.3178,601 shs$46.00 million08/14/2025$2.28$2.27-0.44%$2.32$2.1475,076 shs$42.45 million08/13/2025$2.49$2.28-8.43%$2.58$2.20113,328 shs$42.64 million08/12/2025$2.66$2.49-6.39%$2.59$2.4661,997 shs$46.56 million08/11/2025$2.67$2.66-0.37%$2.70$2.5512,097 shs$49.75 million08/08/2025$2.71$2.67-1.48%$2.71$2.5428,903 shs$49.93 million08/07/2025$2.64$2.71+2.65%$2.79$2.6027,651 shs$50.68 million08/06/2025$2.55$2.64+3.53%$2.77$2.5472,103 shs$49.37 million08/05/2025$2.58$2.55-1.16%$2.68$2.4648,185 shs$47.69 million08/04/2025$2.69$2.58-4.09%$2.66$2.4669,652 shs$48.25 million08/01/2025$2.68$2.69+0.37%$2.75$2.5652,807 shs$50.31 million07/31/2025$2.69$2.68-0.37%$2.96$2.6219,055 shs$50.12 million07/30/2025$2.69$2.69$2.82$2.6915,174 shs$50.30 million07/29/2025$2.92$2.69-7.88%$2.97$2.6572,827 shs$50.31 million Related Companies RAPT Stock Chart CCCC Stock Chart TNYA Stock Chart TIL Stock Chart SXTC Stock Chart IMRX Stock Chart NVCT Stock Chart DERM Stock Chart ACTU Stock Chart CRBU Stock Chart Receive KLRS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Kalaris Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KLRS) was last updated on 8/30/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredSmall Washington, DC Group Could Crash US StocksNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredMy NEXT $1 Trillion PredictionJames Altucher is making his next trillion-dollar prediction — and this time, it’s not Apple. He believes Elon...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kalaris Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kalaris Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
